(Q83219194)
Statements
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials (English)
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group
Donald J D'Amico
H N Masonson
Manju Patel
A P Adamis
E T Cunningham
D R Guyer